HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 160 filers reported holding HERON THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.49 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $463,500 | +79813.8% | 450,000 | -10.0% | 0.49% | -13.1% |
| Q2 2023 | $580 | +9.6% | 500,000 | +42.9% | 0.57% | -9.9% |
| Q1 2023 | $529 | -15.4% | 350,000 | +40.0% | 0.63% | -15.8% |
| Q4 2022 | $625 | -99.9% | 250,000 | -9.1% | 0.75% | -42.4% |
| Q3 2022 | $1,161,000 | +108.1% | 275,000 | +37.5% | 1.30% | +118.2% |
| Q2 2022 | $558,000 | -51.2% | 200,000 | 0.0% | 0.59% | -38.1% |
| Q1 2022 | $1,144,000 | +150.3% | 200,000 | +300.0% | 0.96% | +178.3% |
| Q4 2021 | $457,000 | -28.7% | 50,000 | -16.7% | 0.34% | -27.8% |
| Q3 2021 | $641,000 | -17.4% | 60,000 | +20.0% | 0.48% | -14.8% |
| Q2 2021 | $776,000 | -4.3% | 50,000 | 0.0% | 0.56% | -7.0% |
| Q1 2021 | $811,000 | +155.8% | 50,000 | +233.3% | 0.60% | +105.1% |
| Q4 2020 | $317,000 | – | 15,000 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |